418 related articles for article (PubMed ID: 30176114)
1. Relationship between non-alcoholic steatohepatitis, PNPLA3 I148M genotype and bone mineral density in adolescents.
Mosca A; Fintini D; Scorletti E; Cappa M; Paone L; Zicari AM; Nobili V; Byrne CD
Liver Int; 2018 Dec; 38(12):2301-2308. PubMed ID: 30176114
[TBL] [Abstract][Full Text] [Related]
2. Validation of PNPLA3 polymorphisms as risk factor for NAFLD and liver fibrosis in an admixed population.
Mazo DF; Malta FM; Stefano JT; Salles APM; Gomes-Gouvea MS; Nastri ACS; Almeida JR; Pinho JRR; Carrilho FJ; Oliveira CP
Ann Hepatol; 2019; 18(3):466-471. PubMed ID: 31054980
[TBL] [Abstract][Full Text] [Related]
3. Effect of PNPLA3 polymorphism on diagnostic performance of various noninvasive markers for diagnosing and staging nonalcoholic fatty liver disease.
Liu WY; Zheng KI; Pan XY; Ma HL; Zhu PW; Wu XX; Rios RS; Targher G; Byrne CD; Wang XD; Chen YP; Zheng MH
J Gastroenterol Hepatol; 2020 Jun; 35(6):1057-1064. PubMed ID: 31677195
[TBL] [Abstract][Full Text] [Related]
4. Association of single nucleotide polymorphism at PNPLA3 with fatty liver, steatohepatitis, and cirrhosis of liver.
Alam S; Islam MS; Islam S; Mustafa G; Saleh AA; Ahmad N
Indian J Gastroenterol; 2017 Sep; 36(5):366-372. PubMed ID: 28975533
[TBL] [Abstract][Full Text] [Related]
5. I148M variant of PNPLA3 increases the susceptibility to non-alcoholic fatty liver disease caused by obesity and metabolic disorders.
Xia MF; Ling Y; Bian H; Lin HD; Yan HM; Chang XX; Li XM; Ma H; Wang D; Zhang LS; Wang SS; Wu BJ; He WY; Zhao NQ; Gao X
Aliment Pharmacol Ther; 2016 Mar; 43(5):631-42. PubMed ID: 26765961
[TBL] [Abstract][Full Text] [Related]
6. Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma.
Liu YL; Patman GL; Leathart JB; Piguet AC; Burt AD; Dufour JF; Day CP; Daly AK; Reeves HL; Anstee QM
J Hepatol; 2014 Jul; 61(1):75-81. PubMed ID: 24607626
[TBL] [Abstract][Full Text] [Related]
7. PNPLA3 genotype increases susceptibility of nonalcoholic steatohepatitis among obese patients with nonalcoholic fatty liver disease.
Tai CM; Huang CK; Tu HP; Hwang JC; Chang CY; Yu ML
Surg Obes Relat Dis; 2015; 11(4):888-94. PubMed ID: 25240529
[TBL] [Abstract][Full Text] [Related]
8. Interactions of a PPARGC1A Variant and a PNPLA3 Variant Affect Nonalcoholic Steatohepatitis in Severely Obese Taiwanese Patients.
Tai CM; Huang CK; Tu HP; Hwang JC; Yeh ML; Huang CF; Huang JF; Dai CY; Chuang WL; Yu ML
Medicine (Baltimore); 2016 Mar; 95(12):e3120. PubMed ID: 27015186
[TBL] [Abstract][Full Text] [Related]
9. Role of the PNPLA3 I148M polymorphism in nonalcoholic fatty liver disease and fibrosis in Korea.
Lee SS; Byoun YS; Jeong SH; Woo BH; Jang ES; Kim JW; Kim HY
Dig Dis Sci; 2014 Dec; 59(12):2967-74. PubMed ID: 25069572
[TBL] [Abstract][Full Text] [Related]
10. The I148M PNPLA3 polymorphism influences serum adiponectin in patients with fatty liver and healthy controls.
Valenti L; Rametta R; Ruscica M; Dongiovanni P; Steffani L; Motta BM; Canavesi E; Fracanzani AL; Mozzi E; Roviaro G; Magni P; Fargion S
BMC Gastroenterol; 2012 Aug; 12():111. PubMed ID: 22898488
[TBL] [Abstract][Full Text] [Related]
11. Association of PNPLA3 rs738409 G/C gene polymorphism with nonalcoholic fatty liver disease in children: a meta-analysis.
Tang S; Zhang J; Mei TT; Guo HQ; Wei XH; Zhang WY; Liu YL; Liang S; Fan ZP; Ma LX; Lin W; Liu YR; Qiu LX; Yu HB
BMC Med Genet; 2020 Aug; 21(1):163. PubMed ID: 32811452
[TBL] [Abstract][Full Text] [Related]
12. Independent and joint correlation of PNPLA3 I148M and TM6SF2 E167K variants with the risk of coronary heart disease in patients with non-alcoholic fatty liver disease.
Wu JT; Liu SS; Xie XJ; Liu Q; Xin YN; Xuan SY
Lipids Health Dis; 2020 Feb; 19(1):29. PubMed ID: 32093693
[TBL] [Abstract][Full Text] [Related]
13. The rs2294918 E434K variant modulates patatin-like phospholipase domain-containing 3 expression and liver damage.
Donati B; Motta BM; Pingitore P; Meroni M; Pietrelli A; Alisi A; Petta S; Xing C; Dongiovanni P; del Menico B; Rametta R; Mancina RM; Badiali S; Fracanzani AL; Craxì A; Fargion S; Nobili V; Romeo S; Valenti L
Hepatology; 2016 Mar; 63(3):787-98. PubMed ID: 26605757
[TBL] [Abstract][Full Text] [Related]
14. Association between PNPLA3 rs738409 polymorphism and nonalcoholic fatty liver disease (NAFLD) susceptibility and severity: A meta-analysis.
Dai G; Liu P; Li X; Zhou X; He S
Medicine (Baltimore); 2019 Feb; 98(7):e14324. PubMed ID: 30762732
[TBL] [Abstract][Full Text] [Related]
15. PNPLA3 rs738409 I748M is associated with steatohepatitis in 434 non-obese subjects with hepatitis C.
Petta S; Vanni E; Bugianesi E; Rosso C; Cabibi D; Cammà C; Di Marco V; Eslam M; Grimaudo S; Macaluso FS; McLeod D; Pipitone RM; Abate ML; Smedile A; George J; Craxì A
Aliment Pharmacol Ther; 2015 May; 41(10):939-48. PubMed ID: 25801076
[TBL] [Abstract][Full Text] [Related]
16. The Expression of PNPLA3 Polymorphism could be the Key for Severe Liver Disease in NAFLD in Hispanic Population.
Martínez LA; Larrieta E; Kershenobich D; Torre A
Ann Hepatol; 2017 November-December,; 16(6):909-915. PubMed ID: 29055919
[TBL] [Abstract][Full Text] [Related]
17. The PNPLA3 I148M polymorphism is associated with insulin resistance and nonalcoholic fatty liver disease in a normoglycaemic population.
Wang CW; Lin HY; Shin SJ; Yu ML; Lin ZY; Dai CY; Huang JF; Chen SC; Li SS; Chuang WL
Liver Int; 2011 Oct; 31(9):1326-31. PubMed ID: 21745282
[TBL] [Abstract][Full Text] [Related]
18. The PNPLA3 rs738409 C > G polymorphism is associated with the risk of progression to cirrhosis in NAFLD patients.
Vespasiani-Gentilucci U; Gallo P; Porcari A; Carotti S; Galati G; Piccioni L; De Vincentis A; Dell'Unto C; Vorini F; Morini S; Riva E; Picardi A
Scand J Gastroenterol; 2016 Aug; 51(8):967-73. PubMed ID: 27150500
[TBL] [Abstract][Full Text] [Related]
19. Relationships between Genetic Variations of PNPLA3, TM6SF2 and Histological Features of Nonalcoholic Fatty Liver Disease in Japan.
Akuta N; Kawamura Y; Arase Y; Suzuki F; Sezaki H; Hosaka T; Kobayashi M; Kobayashi M; Saitoh S; Suzuki Y; Ikeda K; Kumada H
Gut Liver; 2016 May; 10(3):437-45. PubMed ID: 26610348
[TBL] [Abstract][Full Text] [Related]
20. Association of PNPLA3 Polymorphism with Hepatocellular Carcinoma Development and Prognosis in Viral and Non-Viral Chronic Liver Diseases.
Khlaiphuengsin A; Kiatbumrung R; Payungporn S; Pinjaroen N; Tangkijvanich P
Asian Pac J Cancer Prev; 2015; 16(18):8377-82. PubMed ID: 26745088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
